ARTA
GALT icon

A.R.T. Advisors’s Galectin Therapeutics GALT Stock Holding History

A.R.T. Advisors’s Portfolio GALT Stock Details GALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-12,477
Closed -$36K – 406
2019
Q4 		$36K Sell
12,477
-2,500
-17% -$8.69K ﹤0.01% 1264
2019
Q3 		$55K Buy
+14,977
New +$54.1K ﹤0.01% 1311
2018
Q3 		– Sell
-31,882
Closed -$202K – 1495
2018
Q2 		$202K Sell
31,882
-25,893
-45% -$126K 0.01% 1227
2018
Q1 		$273K Buy
57,775
+21,704
+60% +$101K 0.01% 1166
2017
Q4 		$120K Buy
+36,071
New +$91.2K 0.01% 1234
2017
Q3 		– Sell
-45,843
Closed -$112K – 1453
2017
Q2 		$112K Buy
+45,843
New +$122K 0.01% 1243
2017
Q1 		– Sell
-31,740
Closed -$31K – 1511
2016
Q4 		$31K Buy
+31,740
New +$28.2K ﹤0.01% 1232
2016
Q3 		– Sell
-16,110
Closed -$23K – 822
2016
Q2 		$23K Buy
+16,110
New +$23.6K ﹤0.01% 1296
2016
Q1 		– Sell
-32,353
Closed -$53K – 1465
2015
Q4 		$53K Buy
+32,353
New +$74.1K ﹤0.01% 1379
2015
Q1 		– Sell
-39,123
Closed -$135K – 1509
2014
Q4 		$135K Sell
39,123
-42,101
-52% -$186K 0.01% 1284
2014
Q3 		$408K Buy
+81,224
New +$633K 0.02% 832

Other funds holding GALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

A.R.T. Advisors's GALT Position: Q1 2020 in Review

A.R.T. Advisors sold out of Galectin Therapeutics (GALT) in Q1 2020, closing a stake of 12,477 shares — an estimated $36K sold.

A.R.T. Advisors first reported a position in GALT in Q3 2014 and held it in 11 quarters. The position peaked at $408K in Q3 2014. 77 funds tracked by Wall St. Rank hold GALT as of Q1 2020.

  • A.R.T. Advisors reported no remaining Galectin Therapeutics position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 12,477 Galectin Therapeutics shares in Q1 2020, an estimated $36K.
  • A.R.T. Advisors first reported a position in Galectin Therapeutics in Q3 2014 and held it in 11 quarters.
  • A.R.T. Advisors's Galectin Therapeutics position peaked at $408K in Q3 2014.
  • 77 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.